ACT Signature Webinars

Applications of iPS-Cell Derived Tissues in Safety Assessment 

09-22-2015 02:17 PM

Speaker: Dr. Kyle Kolaja, Vice President, Business Develpment, Cellular Dynamics International

In collaboration with: British Toxicology Society, SOT Stem Cells Specialty Section,
Society of Toxicologic Pathology, and the Teratology Society

The ability to make pluripotent stem cells from adult somatic cells has revolutionized cell biology, especially as access to differentiated tissues from induced pluripotent stem cells has improved. Differentiated cells from induced pluripotent cell are more similar to intact tissue than cell lines or primary culture and rodents thus have begun to change the standard models to more human in vitro-based models. In this talk, I will highlight the numerous examples where stem cell-derived tissues have replaced, refined, and/or reduced the reliance on animal models in drug screening, toxicology, and product safety.

View Webinar Recording

Webinar materials are property of the speaker and the American College of Toxicology and are intended for use by the host society and cohost societies' members for educational purposes only. Any distribution or copy of the materials is prohibited. By downloading from the link provided you agree to the terms expressed above.

0 Favorited
1 Files
pdf file
ACT_Kolaja2.pdf   3.70 MB   1 version
Uploaded - 08-27-2020

Related Entries and Links

No Related Resource entered.